Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

10.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.1K
Amyloid Fibrils03:03

Amyloid Fibrils

5.2K
5.2K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

739
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
739
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.5K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.5K
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

4.3K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
4.3K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

11
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026
Same author

Multi-target approaches to prion disease drug discovery: a status update.

Expert opinion on drug discovery·2026
Same author

Detection of TDP-43 seeds in CSF of presymptomatic and symptomatic genetic FTD/ALS.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

How Sup35 monomer conformation and amyloid fibril polymorphism determine yeast strain phenotypes.

Research square·2025
Same author

Substitution of histidine 95 by tyrosine in the prion protein causes spontaneous neurodegeneration in transgenic mice.

PLoS pathogens·2025
Same author

Advancing Prion Diagnostics: RT-QuIC Applications in Peripheral Tissues.

Sub-cellular biochemistry·2025
Same journal

An exploratory analysis of disulfidptosis-related gene signatures in minimal change disease identifies metabolic and immune associations.

Frontiers in cell and developmental biology·2026
Same journal

Longitudinal changes in the phenotypic profile of circulating extracellular vesicles in healthy individuals.

Frontiers in cell and developmental biology·2026
Same journal

Mesenchymal stem cells in intrahepatic and extrahepatic biliary diseases: mechanisms and therapeutic applications.

Frontiers in cell and developmental biology·2026
Same journal

CD109 exhibits a dynamic expression pattern in coronary endothelium and endocardial-derived valve mesenchyme during heart development with preserved morphogenesis following endothelial-specific deletion.

Frontiers in cell and developmental biology·2026
Same journal

Significance of fatty acid metabolism regulators in the diagnosis and subtype classification in non-alcoholic fatty liver disease.

Frontiers in cell and developmental biology·2026
Same journal

Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities.

Frontiers in cell and developmental biology·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

2.1K

Prion protein and aging.

Lisa Gasperini1, Giuseppe Legname1

  • 1Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati Trieste, Italy.

Frontiers in Cell and Developmental Biology
|November 4, 2014
PubMed
Summary
This summary is machine-generated.

The cellular prion protein (PrP(C)) is crucial for mammalian cell physiology and may have neuroprotective roles. Its function and biochemical properties change with aging, potentially influencing neurodegenerative disease development.

Keywords:
Alzheimer diseasePrPagingprion diseases

More Related Videos

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
11:57

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans

Published on: November 26, 2017

8.5K
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

10.3K

Related Experiment Videos

Last Updated: Apr 21, 2026

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

2.1K
Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
11:57

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans

Published on: November 26, 2017

8.5K
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

10.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gerontology

Background:

  • The cellular prion protein (PrP(C)) is implicated in prion disorders, sharing high gene homology across mammals and exhibiting high turnover and tissue expression.
  • PrP(C) is suggested to possess key physiological functions, potentially including neuroprotection and antioxidant roles, with relevance to aging and neurodegenerative diseases like Alzheimer's.

Purpose of the Study:

  • To define the roles, properties, and fate of PrP(C) in mammalian cell physiology, particularly in the context of aging.
  • To understand the pathological involvement of PrP(C) in prion diseases and its potential contribution to Alzheimer's disease.

Main Methods:

  • Review of existing literature on PrP(C) function, biochemical properties, and subcellular localization in aging.
  • Analysis of studies investigating PrP(C) changes in aging mice, including post-translational modifications and their relation to protein function and conversion.

Main Results:

  • Evidence suggests PrP(C) plays a neuroprotective and antioxidant role, but its function may be lost upon aggregation in prion diseases.
  • Aging can alter PrP(C) biochemical properties, potentially influencing its conversion to the pathogenic PrP(Sc) isoform, thus contributing to disease progression.
  • PrP(C)'s role in Alzheimer's disease is controversial, potentially mediating amyloid toxicity while its down-regulation correlates with neuronal death.

Conclusions:

  • Understanding PrP(C) functions and fate during aging is crucial for comprehending its role in neurodegenerative disorders.
  • Further research is needed to reconcile contrasting results regarding PrP(C)'s functions in aging, including its involvement in memory, behavior, and myelin maintenance.